Bioperfectus Novel Corona Virus (SARS-CoV-2) IgG/IgM Rapid Test Kit has been granted a Brazil ANVISA Registration.
Antigen tests can be used in a variety of testing strategies to respond to the COVID-19 pandemic.
Bioperfectus is pleased to invite you to join us for Bioperfectus 1st Distributors Conference & New Product Launch 2021.
Bioperfectus donates 6,000 pieces of new coronavirus nucleic acid test kits to Sister cities in Italy and Netherlands
Bioperfectus Aid Materials Greatly Enhancing Guyana's Local Testing Capabilities
Bioperfectus Assisting Namibia in Combating COVID-19!
As Thanksgiving is approaching this year, bioPerfectus would like to express our deep gratitude to all the healthcare workers fighting against the ongoing COVID-19 crisis all the around the world. For your safety and the safety of our community, let’s stay home this Thanksgiving and enjoy a safe, happy family union.
As winter moves in, COVID-19 cases, hospitalizations and the number of deaths across the world are incredibly rising. In all its various methods, testing is and will be a mainstay for the foreseeable future. However, it is critical to choose the method of testing since the best solution may be not the same during the whole progression of COVID-19.
Bioperfectus takes the lead in developing and producing COVID-19 nucleic acid test kits
Bioperfectus Launches New Product-Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit to Combat COVID-19 Globally
